Envista Holdings (NVST) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.40
- Estimate
- $0.36
- Surprise
- +12.4%
- Revenue (period 2026-10-02)
- $691.5M
- Score today
- 6.3/10
Revenue source: xbrl.
How the report landed
Envista Holdings (NVST) beat the $0.36 estimate with adjusted EPS of $0.40 — a large 12.4% upside surprise.
Where TrendMatrix's rating stands now
TrendMatrix currently rates NVST Hold at 6.3/10; no pre/post engine snapshot brackets this report.
4 of the last 4 quarters beat the estimate; this quarter's +12.4% surprise compares with a +16.8% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Concentration risk — Geographic: North America (51.0%)
- Concentration risk — Supplier: sole or limited source suppliers
- Analyst target reached - limited upside remaining
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $27.19
- Stop
- $25.39
The stock trades at 46.9× trailing but 16.4× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 72 — a level conventionally read as overbought; gains at these levels often lean on momentum; trading volume is running 1.8× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-11-05 — shown for context, not personalized investment advice.
NVST at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Instruments & Supplies
- Market cap
- $4.37B
- P/E (fwd)
- 16.4
- P/E (ttm)
- 46.9
- 52-week range
- $18.77–$30.42
- Off 52-week high
- 10.6%
- RSI (14)
- 72
- Volume vs avg
- 1.83×
- Score today
- 6.3/10